What patent covers Diamox (acetazolamide)?
Diamox is the brand name for acetazolamide, a medicine that has been on the market for decades. Because the drug’s active ingredient is not new, the most relevant “Diamox patent” questions usually come down to one of these:
- Patents on specific formulations or combinations (for example, extended-release versions, fixed-dose combinations, or specific drug-device packaging).
- Patents tied to later regulatory filings (for example, changes in manufacturing, dosing forms, or generic-entry protection depending on the country).
- Patent disputes involving generic manufacturers trying to market an acetazolamide product.
Without a jurisdiction (US/Europe/UK/Canada/etc.) and the exact product (tablet strength, formulation type), it’s not possible to name the controlling patent with confidence.
Has the Diamox (acetazolamide) patent already expired?
In general, acetazolamide is an older drug, so patents that protect the original active ingredient are typically long expired. What still may exist are later patents on particular formulations or ways of making the drug, which can extend protection for certain products even after the original compound patents have expired.
To answer “has it expired?” precisely, you need:
- Country or regulator (FDA vs EMA vs others)
- Product type (immediate-release tablet vs any modified-release form)
- Company/product you’re tracking (brand vs a specific generic)
When does Diamox exclusivity expire in the US?
In the US, exclusivity and patent protection for a brand product can involve multiple layers (patents listed in the Orange Book plus other exclusivity periods). For acetazolamide products, the brand’s original compound protection is usually outdated, so any remaining time-to-entry often depends on whether a specific manufacturer has formulation or method patents still listed for that specific NDC (strength/form).
If you tell me the exact Diamox product (strength and dosage form) and whether you mean Orange Book “patent expiry” or “FDA exclusivity,” I can narrow the answer.
What does “patent expiry” mean for generic Diamox?
Patent expiry matters because generics generally rely on challenging patent claims or waiting until they expire (and/or until exclusivity ends) before launching the same type of product. If a remaining formulation patent exists, a generic may:
- Launch anyway if it’s not protected by the specific patent(s) listed for the product, or if patents are invalid/unenforceable in litigation.
- Delay launch if it cannot obtain approval under the appropriate patent status until later.
How can I find the exact Diamox patent numbers?
The fastest way is usually to look up the specific product in the relevant patent registry, then match by:
- Active ingredient: acetazolamide
- Dosage form (tablet/capsule, etc.)
- Strength
- Country/agency (US FDA Orange Book is common in the US)
If you share the jurisdiction (e.g., “US”) and the Diamox NDC/strength (or at least the country), I can help identify what to search for and how to interpret the listing.
What if you mean “Diamox” as a treatment patent, not the drug?
Sometimes people search “Diamox patent” but actually mean protection around a specific use (an indication) such as off-label applications. Patents on new methods of use are possible for many older drugs, but whether any exist depends on filings and jurisdictions.
If you tell me the indication (for example, glaucoma, altitude sickness prevention, intracranial pressure-related uses), I can tailor the search logic.
---
Sources
No sources were provided with the question, so I can’t cite specific patent numbers or dates.